Aspirin also targets metabolic pathways via activation of AMPK and inhibition of mTOR [101,115]; notably, these are also important in the anti-cancer activities of metformin, and there is some interest in exploring the potential synergy of the two drugs in cancer treatment [116,117]. Here, MTOR is linked to cancer.